Plain-English translation of NCT04154683 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new technology called Cellvizio® optical biopsy, which creates detailed, real-time images of tissue during gynecological surgery. Instead of waiting for lab results after surgery, doctors can see cell-level details instantly while operating. The goal is to help surgeons make better decisions during surgery and remove diseased tissue more accurately.
Currently, surgeons sometimes have to wait for lab results after surgery to confirm what tissue they've removed or whether they got all of a diseased area. This new technology could give surgeons immediate answers during surgery, helping them be more precise and potentially improving patient outcomes.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would undergo your planned gynecological surgery as scheduled. During the surgery, your surgeon would use the Cellvizio® imaging technology to view tissue in real time and guide their decisions about what to remove and how much to remove. The imaging itself does not require extra steps or extend your surgery time significantly. After surgery, your care would proceed normally.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
France